The DOI matches its Crossref record.
Human C-reactive protein is protective against fatal Streptococcus pneumoniae infection in transgenic mice
Abstract
C-reactive protein (CRP) is an acute phase protein with a well known association with infection and other inflammatory conditions. Studies with use of purified CRP in in vitro assays provided early evidence that CRP has antibacterial activity. Subsequently it was shown that passively administered human CRP can protect mice from lethal infection with Streptococcus pneumoniae. In this study, we extend these observations to an in vivo model of host resistance by using human CRP transgenic mice. CRP transgenic mice experimentally infected with S. pneumoniae lived longer and had significantly lower mortality than their nontransgenic littermates. This increased resistance to infection was associated with q 10- to 400-fold reduction of bacteremia. Furthermore, male transgenics exhibited longer survival time than females, and this difference could be attributed to increased expression of CRP by males, which was mediated by testosterone. This study provides the first unequivocal evidence that CRP plays an important role in vivo in host defense against pneumococcal infections, and shows that sex hormones can affect expression of the human CRP transgene in mice.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Black, S., Kushner, I., & Samols, D. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.r400025200 · Cited by 1,844
The role of Streptococcus pneumoniae virulence factors in host respiratory colonization and disease
Kadioglu, A., Weiser, J. N., Paton, J. C., & Andrew, P. W. (2008) · Nature Reviews Microbiology · doi:10.1038/nrmicro1871 · Cited by 1,146
Human C-reactive protein: expression, structure, and function
Volanakis, J. (2001) · Molecular Immunology · doi:10.1016/s0161-5890(01)00042-6 · Cited by 926
Self-citationGarlanda, C., Bottazzi, B., Bastone, A., & Mantovani, A. (2005) · Annual Review of Immunology · doi:10.1146/annurev.immunol.23.021704.115756 · Cited by 836
Function of C-reactive protein
Du Clos, T. W. (2000) · Annals of Medicine · doi:10.3109/07853890009011772 · Cited by 801
Early inflammation and dementia: A 25‐year follow‐up of the Honolulu‐Asia aging study
Schmidt, R., Schmidt, H., Curb, J. D., Masaki, K., White, L. R., & Launer, L. J. (2002) · Annals of Neurology · doi:10.1002/ana.10265 · Cited by 710
C-reactive protein: Ligands, receptors and role in inflammation
Marnell, L., Mold, C., & Du Clos, T. W. (2005) · Clinical Immunology · doi:10.1016/j.clim.2005.08.004 · Cited by 627
Pathogenesis and Pathophysiology of Pneumococcal Meningitis
Mook-Kanamori, B. B., Geldhoff, M., van der Poll, T., & van de Beek, D. (2011) · Clinical Microbiology Reviews · doi:10.1128/cmr.00008-11 · Cited by 492
Cellular effectors mediating Th17-dependent clearance of pneumococcal colonization in mice
Zhang, Z., Clarke, T. B., & Weiser, J. N. (2009) · Journal of Clinical Investigation · doi:10.1172/jci36731 · Cited by 456
C-Reactive Protein Levels Correlate With Mortality and Organ Failure in Critically Ill Patientsa
Lobo, S. M. A., Lobo, F. R. M., Bota, D. P., Lopes-Ferreira, F., Soliman, H. M., Meélot, C., & Vincent, J.-L. (2003) · Chest · doi:10.1378/chest.123.6.2043 · Cited by 448
C-Reactive Protein: An Activator of Innate Immunity and a Modulator of Adaptive Immunity
Du Clos, T. W., & Mold, C. (2004) · Immunologic Research · doi:10.1385/ir:30:3:261 · Cited by 407
C-reactive protein: a valuable marker of sepsis
Póvoa, P. (2002) · Intensive Care Medicine · doi:10.1007/s00134-002-1209-6 · Cited by 403
Natural pathogens of laboratory mice, rats, and rabbits and their effects on research
Baker, D. G. (1998) · Clinical Microbiology Reviews · doi:10.1128/cmr.11.2.231 · Cited by 394
C-Reactive Protein Accelerates the Progression of Atherosclerosis in Apolipoprotein E–Deficient Mice
Paul, A., Ko, K. W. S., Li, L., Yechoor, V., McCrory, M. A., Szalai, A. J., & Chan, L. (2004) · Circulation · doi:10.1161/01.cir.0000114526.50618.24 · Cited by 373
Self-citationRegulation of complement activation by C-reactive protein
Mold, C., Gewurz, H., & Du Clos, T. W. (1999) · Immunopharmacology · doi:10.1016/s0162-3109(99)00007-7 · Cited by 326
Interleukin 1 receptor antagonist (IL-1Ra) is an acute-phase protein.
Gabay, C., Smith, M. F., Eidlen, D., & Arend, W. P. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119488 · Cited by 319
Di Napoli, M., Schwaninger, M., Cappelli, R., Ceccarelli, E., Di Gianfilippo, G., Donati, C., Emsley, H. C. A., Forconi, S., Hopkins, S. J., Masotti, L., et al. (2005) · Stroke · doi:10.1161/01.str.0000165929.78756.ed · Cited by 289
Increased Thrombosis After Arterial Injury in Human C-Reactive Protein–Transgenic Mice
Danenberg, H. D., Szalai, A. J., Swaminathan, R. V., Peng, L., Chen, Z., Seifert, P., Fay, W. P., Simon, D. I., & Edelman, E. R. (2003) · Circulation · doi:10.1161/01.cir.0000085568.13915.1e · Cited by 285
Self-citationC-reactive protein: structure, function, regulation, and role in clinical diseases
Zhou, H.-H., Tang, Y.-L., Xu, T.-H., & Cheng, B. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1425168 · Cited by 162
The Pentraxins 1975–2018: Serendipity, Diagnostics and Drugs
Pepys, M. B. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02382 · Cited by 67
Sick euthyroid syndrome is associated with decreased TR expression and DNA binding in mouse liver
Beigneux, A. P., Moser, A. H., Shigenaga, J. K., Grunfeld, C., & Feingold, K. R. (2003) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00155.2002 · Cited by 64
Metadata
- Authors
- Szalai, A. J., Briles, D. E., & Volanakis, J. E.
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 1995-09-01
- Volume
- 155
- Issue
- 5
- Pages
- 2557-2563
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- OpenAlex
- W1570456520
- Cited by
- 203
- References
- 0
- FWCI
- 3.05
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.